Emerging Regulatory Issues in Genomic Medicine

21 - 23 May 2008, Mexico City, Mexico

Introduction

The purpose of this meeting is to identify synergies and common issues in Genomic Medicine and to develop common approaches to address these issues. The FDA has a major effort in the area of genomics and personalized medicine. It is working with clinicians, the pharmaceutical industry, and other regulatory agencies worldwide to integrate genomic medicine into medical practice.